Company ProfilePremium

Quantum Foods Holdings Ltd

Company Profile Analysis

Ticker: QFH.JO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Quantum Foods Holdings Ltd - Company showcase

Year Founded & Workforce

2013

2 Employees

Quantum Foods Holdings Ltd logo

Quantum Foods Holdings Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Quantum Foods Holdings Ltd Overview

FieldDetailSource
Legal nameQuantum Foods Holdings LimitedHY2026 interim financial statements
Former namesNone as a listed entity. Before October 2014 the business operated as the Quantum Foods division/subsidiary of Pioneer Food GroupEngineering News, 5 Sep 2014
Registration number2013/208598/06All SENS filings
Incorporation2013, Republic of South Africa (Companies Act 71 of 2008)2025 Integrated Report
ListingJSE Main Board, Prime Segment, since 2014 (unbundled from Pioneer Foods)2025 IR; Engineering News 2014
TickerQFH (JSE); QFH.JO (Refinitiv-style)SENS
ISINZAE000193686SENS
CUSIPNot applicable (no US listing)—
Headquarters11 Main Road, Wellington 7655, Western Cape, South AfricaHY2026 interims
Fiscal year end30 SeptemberAFS FY2025
AuditorErnst & Young Inc. (designated auditor: PG (Pierre) du Plessis), appointed for FY2024 onward. Predecessor: PricewaterhouseCoopers Inc. (to FY2022/FY2023)AFS FY2025; FY2022 summary results
Internal auditOutsourced to Deloitte & ToucheAFS FY2025 ARC report
JSE sponsorValeo Capital (Pty) Ltd from 24 June 2026. Previously One Capital Sponsor ServicesSENS 24 Jun 2026
Transfer secretaryComputershare Investor Services (Pty) LtdHY2026 interims
Company secretaryZiyanda Patience Wakashe (appointed 20 Sep 2022)FY2022 summary results
Websitehttps://quantumfoods.co.zaCompany website
Shares in issue204 097 828 (no treasury shares), as at 5 Oct 2026SENS 5 Oct 2026
Share price (close)741 cents (13 Oct 2026)ShareData / JSE
Market capitalisation~ZAR 1 512 M (741c x 204.1 M shares; analyst-computed)Derived
Employees2 572 (FY2025), 2 425 (FY2024). FY2023 n/d in sources reviewed2025 IR
Operating countries4 (South Africa, Zambia, Uganda, Mozambique)2025 IR
B-BBEE levelLevel 8 (FY2025 and FY2024)2025 IR

Entity verification note

The identification details supplied (South Africa, JSE, QFH.JO, quantumfoods.co.za) match the entity profiled. There has been no name change and no change of listing. Quantum Foods Holdings Ltd remains listed on the JSE as at 14 October 2026.

An unrelated US company, Quantum Foods LLC (Bolingbrook, Illinois), went through Chapter 11 and was sold to Raging Bull Acquisition Co (Oaktree). It shares the name only.

Quantum Foods is a mid-sized, vertically integrated African protein producer spanning animal feed, poultry genetics and breeding, hatcheries, contract broiler farming, commercial layer farming and egg packing and distribution. It operates in South Africa, Zambia, Uganda and Mozambique.

Its revenue is ZAR 7.15 bn (FY2025). Animal feeds is the largest segment (46% of revenue), followed by broiler and layer farming (28%), eggs (18%) and other African operations (8%).

Quantum is one of South Africa's largest egg producers (Nulaid brand) and a long-term contract supplier of live broilers to Astral Foods' County Fair abattoir. It also holds the Lohmann layer-genetics licence for South Africa.

Since FY2024 the business has recovered from the 2023–2024 avian influenza crisis, delivering one of its best profit years since listing in FY2025, a net-cash balance sheet and a reinstated dividend. The equity story is dominated by a concentrated, contested shareholder register (four blockholders holding roughly 97%) and a protracted governance dispute. These factors suppress liquidity and the valuation multiple.


Company's own description (paraphrased from the 2025 Integrated Report)

Quantum describes itself as a diversified business built around animal feed, poultry and eggs. It operates in fragmented market segments where it is one of a few high-volume producers serving livestock farmers, processors and retailers in South Africa and selected other African markets.

Its stated purpose is to produce affordable, quality products responsibly. Its stated vision is to be the leading feed, poultry, livestock and protein business in Africa. It anchors its sustainability narrative in UN SDGs 2 (zero hunger), 8 (decent work) and 12 (responsible production).

Business model

Product lineFY2025Share of group
Animal feeds3,391.747.5%
Broiler farming (day-old broiler chicks, live broilers)1,787.025.0%
Eggs (shell and liquid)1,603.822.4%
Layer farming (hatching eggs, day-old pullets, point-of-lay hens)364.15.1%
Total7,146.5100%

The group is a product-sales business. Revenue under IFRS 15 consists solely of the sale of goods: animal feed, livestock (day-old chicks, point-of-lay hens, live broilers, hatching eggs) and agricultural produce (eggs). There are no subscription, licensing or service revenue lines (AFS FY2025, accounting policy 14). Technical advisory services are bundled with feed sales and are not separately monetised.

Revenue by product type, FY2025 (ZAR M; AFS FY2025 revenue disaggregation, group-wide)

Value-chain position

Quantum is integrated from grandparent layer stock (Lohmann licence) and broiler parent stock (Ross 308) through to finished table eggs on retail shelves. It deliberately does not slaughter or process broilers. Since 2014 it has supplied live birds under long-term agreements, chiefly to Astral's County Fair operation in the Western Cape, and receives compensation for production risk rather than exposure to chicken-meat pricing (FY2022 summary results).

Its internal value flow runs as follows:

  • Feed mills supply internal farms (about 33% of FY2025 feed volume was consumed internally, versus 29% in FY2024).

  • Hatcheries supply internal and external farms.

  • Commercial layer farms supply the Nulaid egg business.

  • About 12% of FY2025 egg volume was bought from contracted external producers (15% in FY2024).

Customer types and end-markets

Commercial livestock farmers: (poultry, dairy, pig, ostrich, sheep): Nova Feeds customers.

Emerging and informal farmers: served through the bag-feed and depot model, mainly in the northern regions and Limpopo.

Commercial abattoirs: live broilers. Astral is the largest customer in the Western Cape broiler business.

Commercial egg producers: buyers of day-old pullets and point-of-lay hens, in South Africa and for export (Namibia, Eswatini, Angola).

Formal retail: branded and private-label shell eggs. Formal retail fell from 58.9% to 46.2% of egg volumes in FY2025 as the mix shifted.

Informal trade: spaza shops, wholesalers and hawkers via depots, under the Quantum Nest Eggs brand.

Industrial customers: liquid and pasteurised egg products.

Rest of Africa: feed, chicks and eggs sold through owned retail outlets (49 in Zambia), agents and direct farm sales.

Independent characterisation

Quantum is best understood as three different earnings engines with different cyclicality:

  1. Feed and broiler farming: a cost-plus, volume-driven engine. Input-cost changes are passed through in selling prices, so earnings depend on volumes and efficiency. The company itself describes these units as more resilient to feed-cost swings.

  2. Eggs and layer livestock: a commodity-spread engine. Egg prices are set by national supply and demand, not by production cost. Earnings therefore swing violently with the national layer-flock cycle, feed costs and avian influenza. Examples: an eggs adjusted operating loss of ZAR 42 M in FY2023 followed by a ZAR 140 M profit in FY2024, on lower revenue.

  3. Other African countries: a small, higher-margin diversifier. It is exposed to currency translation (kwacha, shilling, metical), local grain harvests and political risk.

The strategic direction since FY2024 is to grow engine (1), rightsize engine (2) to about two-thirds of its pre-HPAI scale, and expand engine (3). The aim is to reduce earnings volatility.

Strategy

Stated strategy (2025 IR)

The strategy, adopted in FY2024, is titled "Re-focus, optimise and grow" and rests on five pillars:

  1. Optimise business portfolio: clarity on each segment's strategic role and capital-allocation directives.

  2. Growth: grow, scale or de-risk units to achieve sustainable profitability.

  3. Efficient operations and customer focus, underpinned by four "drivers of success": quality, efficient operations, product performance and world-class customer service.

  4. Human capital management: a people-centred business.

  5. Organisational health: decentralised ownership, a reinvented culture and trust.

The 2026–2030 objectives (2025 IR) are to:

  • Pursue growth in less cyclical segments (feed and broiler farming).

  • Expand market share in South African day-old layer chicks.

  • Explore Lohmann genetics opportunities.

  • Position Zambia as a growth hub for the rest of Africa.

  • Expand process automation and AI in planning, flock-health monitoring, maintenance, logistics, recruitment and customer service.

Segment mandates (2025 IR)

SegmentMandate
Animal feedsGrow volumes, share and earnings using the Malmesbury capacity
EggsExpect a "very challenging" FY2026, with cycle recovery forecast in 18–24 months. The business has been rightsized to about two-thirds of its pre-HPAI size, and sales will be redirected to more favourable channels
Broiler farmingGrow volumes through the Western Cape breeder-to-broiler conversion; become self-sufficient in breeder eggs
Bergvlei layer farmingHigher day-old chick volumes and exports; disciplined point-of-lay planning
Internal layer farmingSustain efficiency; no growth unless HPAI vaccination becomes viable
ZambiaGrow through investment in Mega eggs and higher feed and chick sales over three years
UgandaMaintain strong results
MozambiqueFollow the SA egg cycle; seek a partner or corporate transaction

Strategic initiatives announced in the last 24 months

InitiativeStatus (latest)Investment / targetSource
Malmesbury feed-mill expansionCompleted Feb 2026; expected to support H2 FY2026 earningsZAR 194 M approved Apr 20242025 IR; HY2026
Gauteng broiler and layer-rearing farms converted to broiler breedersCompleted FY2025; driving HY2026 broiler earningsZAR 56 M retrofits and technology (FY2025)AFS FY2025
Western Cape breeder farm converted to broiler farmPhase 1 near completion at Mar 2026; first placements May 2026+~6% live-bird capacityHY2026
Layer-breeder outsourcing / regional dispersalImplemented; 4 of 6 breeder farms have Quantum-owned birdsRisk mitigationAFS FY2025
Leased Western Cape layer hatcheryStart-up phase in HY2026—HY2026
On-farm hatching pilotTrial underway; business case due FY2026—2025 IR
Zambian Copperbelt egg and feed expansionLand acquired; construction from H2 FY2026; multi-yearn/d (part of ZAR 313.9 M uncontracted capex commitments)HY2026
Uganda hatchery and breeder expansion; maize storage7th setter added Sep 2025; further breeder capacity planned—2025 IR
Depot model / Quantum Nest Eggs expansionOngoing—2025 IR
Mozambique corporate transaction / partnerBeing pursued—2025 IR
Digitalisation, automation and AI pilotsPilots in FY2025—AFS FY2025
ESG: climate assessments, solar PV, water resilience, BiobiN® compostingOngoing—2025 IR

Capital commitments (HY2026 note 6)

  • Approved and contracted: ZAR 63.4 M (30 Sep 2025: ZAR 87.3 M).

  • Approved but not yet contracted: ZAR 313.9 M (30 Sep 2025: ZAR 386.5 M).

Medium-term financial targets and guidance

The company publishes no quantitative medium-term financial targets and no numerical earnings guidance. The HY2026 outlook is qualitative:

  • A "significantly more challenging" H2 FY2026 is expected because of Middle East conflict effects on fuel and supply chains, and on consumers' disposable income.

  • Feed input costs are expected to stay relatively low in the short term.

  • Egg prices are expected to remain under pressure.

  • HPAI risk remains high.

  • The absence of load-shedding is positive.

  • Zambia is expected to be stable, Uganda challenged, and Mozambique challenging.

Products & Services

Pricing models are commercial and not disclosed. Feed and broiler prices are described as adjusted in line with input costs. Egg prices are market-determined. Broiler supply contracts compensate Quantum for production risk.

Animal feeds segment

Brand / offeringDescription and capabilitiesTarget customerYear / versionSource
Nova Feeds (flagship feed brand)More than 60 years of heritage. Customised formulations backed by technical advisers. Six feed mills on four SA sites. ISO 9000/14001/45000 and NOSA registration. On-site laboratories test all inputs and outputsCommercial and emerging livestock farmers; internal farms (about 33% of volume)Ongoing2025 IR
Broiler and layer poultry feedMeal, pellet and crumble formats, bulk or baggedBroiler and layer producersOngoing2025 IR
Dairy feedRuminant formulations; FY2025 customer forums improved dairy-herd performanceDairy farmersOngoing2025 IR
Pig feed (fine-grind)Ultra-finely milled feed from the new Malmesbury fine-grinding linePig producersCommissioned Feb 20262025 IR; HY2026
Ostrich and sheep feedSpecialist formulationsOstrich and small-stock farmers (Western and Eastern Cape)Ongoing2025 IR
Bag-feed and depot modelBagged feed with chicks, medication and farm inputs sold through depotsInformal and emerging farmers (northern regions, Limpopo)Expanding since FY2024AFS FY2025
Feed consultingTechnical advice, formulation through the BESTMIX® system, on-farm performance serviceFeed customers (bundled, not separately priced)Ongoing2025 IR
New Malmesbury millZAR 194 M expansion. Fine-grinding, precision mixers, pelleting, cooling. In-line protein and pellet-quality monitoring, a first for the groupWestern Cape pig and broiler customersCompleted Feb 20262025 IR; HY2026

Farming segment — broiler farming

Brand / offeringDescriptionTarget customerYearSource
Bellevue ChixBroiler breeding and hatchery brand: day-old broiler chicks of Ross 308 genetics (migration from Cobb 500 completed by FY2024)Contract and open-market broiler growers; internal farmsRoss 308 conversion completed around 20232025 IR; HY2024
Hatching eggsFrom owned and contracted parent farmsInternal hatcheriesOngoing2025 IR
Live broilersReared on 8 Western Cape broiler farms (6 owned, 2 long-term contracts) under long-term supply agreementsCommercial abattoirs, mainly Astral County Fair (about 600 000 broilers a week, about 35% of County Fair slaughter capacity, per Astral in Mar 2024)Agreement dating from 2014; about five years remaining as of Mar 2024Astral release, 6 Mar 2024
On-farm hatching (pilot)Fertile eggs delivered to farms on day 18 to hatch in climate-controlled houses. Described as the first such trial in Africa; equipment sourced after a Belgian study tour (arrived Jun 2025)Internal broiler operationsBusiness case due FY20262025 IR

Farming segment — layer farming

Brand / offeringDescriptionTarget customerYearSource
Bergvlei ChicksLayer genetics business: grandparent and parent breeding, two hatcheries, rearing farms. Sells day-old parent chicks, day-old commercial pullets, hatching eggs and point-of-lay hensSA commercial egg farmers; exports to Namibia, Eswatini, Angola; indirect supply to Uganda via a Kenyan producerBrand repositioned in FY2025AFS FY2025; 2025 IR
Lohmann geneticsLicence to import pedigree Lohmann grandparent layer stock. Parent stock distributed exclusively in South Africa and non-exclusively in selected African countriesLayer breeders and egg producersOngoing2025 IR
Point-of-lay hens17-week reared hensCommercial egg farmsVolumes +110% in FY2025; -33.7% in HY20262025 IR; HY2026
Day-old pulletsFemale layer chicksExternal and internal rearing+28.1% in FY2025AFS FY2025
Leased Western Cape layer hatcherySecond hatchery province, for HPAI risk dispersalInternal / BergvleiLong-term lease secured FY2025; start-up costs in HY2026AFS FY2025; HY2026

Eggs segment

Brand / offeringDescriptionTarget customerSource
Nulaid (flagship egg brand)Branded shell eggs; FSSC 22000 or Food Safety certified grading and packing stationsFormal retail2025 IR
Quantum Nest EggsValue brand for the informal market, sold through depotsSpaza shops, wholesalers, informal traders2025 IR
Private-label eggsPacked to retailer specificationNational retailers2025 IR
Free-range eggsFrom two dedicated farmsPremium retail2025 IR
Canola eggsSpecialty shell eggsPremium retail2025 IR
Pasteurised shell eggsValue-added shell eggsRetail and food service2025 IR
Liquid egg (fresh and pasteurised)Industrial ingredient; volumes -18.7% in FY2025 after a major customer was lostIndustrial food manufacturersAFS FY2025
Second-grade eggs and end-of-lay birdsBy-products sold at depotsInformal market2025 IR

Other African countries segment

Country / brandProductsFacilitiesSource
Zambia: Mega (Mega Eggs)Day-old pullets, day-old broiler chicks (external only), animal feed, table eggs; 49 company-owned small retail outletsParent breeding (layer and broiler), layer rearing farm, layer farm with packing station plus cull depot, hatchery, two feed mills (Lusaka, Chingola/Copperbelt). New Copperbelt greenfield farm acquired in HY20262025 IR; HY2026
Uganda: Quantum Foods UgandaDay-old pullets, day-old broiler chicks (Ross 308), Sasso-A1 dual-purpose chicks, feed and concentrates, table eggs; agents extend into Kenya, with exports to TanzaniaLayer rearing and laying farm with packing (Masindi), two owned and one rented breeder farms, hatchery (7th setter/hatcher added Sep 2025), feed mill2025 IR
Mozambique: GalovosTable eggs (formal retail including SA retailers in Mozambique, and informal trade)One layer farm and one egg packing facility (Maputo). Feed from third parties; point-of-lay birds from Quantum SA2025 IR

Brand count. The 2025 IR states that the group has 8 commercial brands. Brands identifiable in the IR are Nova Feeds, Bellevue Chix, Bergvlei Chicks, Nulaid, Quantum Nest Eggs, Mega, Galovos and Quantum Foods Uganda. The exact eighth-brand designation could not be confirmed from the text reviewed.

Operating volumes (2025 IR; HY2026 interims)

Volume metricFY2024FY2025HY2026 vs HY2025
Feed supplied (tonnes)671,209731,328-2.6% (external -3.8%)
Day-old chicks produced (million)8286Broiler DOC +9.1%
Eggs and egg products sold (million)531828Egg supply +4.4%
Live broilers—-0.3% YoY+3.3%

Financial Narrative

All figures are audited group figures in ZAR M unless stated. Sources: FY2022 summary results (FY2021–FY2022), HY2024 interims (FY2023 audited column), HY2025 interims (FY2024 audited column), HY2026 interims and AFS FY2025 (FY2025).

Income statement — chartable

EBITDA: n/d. Reference point: as at 31 March 2024 the company reported EBITDA-to-senior-interest covenant cover of 18.14x against a 4.50x minimum (HY2024 interims, note 2).

Margins — chartable (analyst-computed)

Management also reports gross margin excluding realised fair-value adjustments on biological assets and agricultural produce:

  • FY2021: 21.3%

  • FY2022: 18.5%

  • FY2024: 22.1%

  • FY2025: 23.1% (ZAR 1.65 bn)

  • HY2026: 25.2%

  • FY2023: n/d in sources reviewed

Revenue CAGR FY2021–FY2025: 7.3% a year (analyst-computed). Breakdown: South Africa 6.8% a year; Other African countries 14.2% a year.

Balance sheet — chartable

Notes:

  • Negative net debt indicates a net cash position.

  • Goodwill: ZAR 5.4 M (Olifantskop) was fully impaired in FY2022. No goodwill has been recognised since.

  • HY2026 (31 Mar 2026): total assets ZAR 3 675.1 M; cash ZAR 476.4 M; term loan ZAR 69.6 M; leases ZAR 47.1 M. Net cash ZAR 359.7 M including leases. Equity ZAR 2 548.3 M.

Cash flow — chartable

Notes:

Buybacks: none for cancellation in FY2021–FY2025 (AFS FY2025 directors' report). Subsidiaries buy treasury shares only to settle share appreciation rights: ZAR 2.3 M (FY2023), ZAR 8.6 M (FY2024, offset by issue) and ZAR 18.8 M in HY2025 (offset by issue).

HY2026: OCF ZAR 408.7 M (including a working-capital release of ZAR 125.0 M); capex ZAR 152.1 M; dividends paid ZAR 68.8 M.

Ratios — chartable (analyst-computed)

Methodology notes:

ROIC: operating profit x (1 – statutory tax rate of 28% to FY2022 and 27% from FY2023) / (equity + debt including leases – cash).

Cash conversion cycle: receivable days + inventory days – payable days, using year-end balances. It excludes biological assets. Receivables and payables include "other" balances, so the figure is indicative only and is not a company disclosure.

Net debt/EBITDA: not meaningful, because the group was in net cash from FY2023, and EBITDA is n/d.

Trend commentary

FY2021 to FY2022: margin compression.

Revenue rose 11.5% on price pass-through. However, maize and soy costs rose about 15% each, egg prices could not keep pace in a weak consumer market, load-shedding intensified, HPAI struck Lemoenkloof and the Kaalfontein strike disrupted production. Adjusted operating profit fell 74% to ZAR 37 M. A working-capital build of ZAR 259 M in FY2021 pushed free cash flow negative in both years, and the group ended FY2022 with a net overdraft of ZAR 11 M (FY2022 summary results).

FY2023: the trough.

Revenue rose 15.5% to ZAR 6.95 bn, almost entirely from feed price inflation. The H7 HPAI outbreak in the northern provinces destroyed ZAR 155.3 M of birds, equivalent to 56.8c of EPS. Diesel and generator costs rose by about ZAR 87 M (Business Report, Dec 2023). The group posted its first operating loss since listing (ZAR -36 M) and a headline loss of 17.4c. Cash generation nevertheless improved, as working capital unwound and OCF reached ZAR 276 M.

FY2024: revenue down, profit up.

Revenue fell 8.9% as feed volumes dropped and egg volumes collapsed. Scarcity, however, drove egg prices up sharply, and the eggs segment earned ZAR 140 M. Farming still lost ZAR 11 M, after a further ZAR 37 M in HPAI write-offs. HEPS recovered to 80.4c. The RMB term loan of ZAR 100 M lifted liquidity; cash ended at ZAR 246 M.

FY2025: volume-led recovery.

Revenue rose 12.9% to ZAR 7.15 bn, with egg volumes up 79.5% and feed volumes up 8.7%. Farming swung to a ZAR 127 M profit. The CFO described it as one of the best profit performances since the unbundling. Head-office costs fell from ZAR 37 M to ZAR 23 M as spending on corporate and legal matters declined. Capex nearly doubled to ZAR 261 M (Malmesbury mill, breeder-farm conversions), which compressed free cash flow to about ZAR 40 M. A dividend of 34c was reinstated.

HY2026: margin-led inflection.

Revenue fell 4.8% on lower feed prices and egg prices (-8.8%). Gross margin excluding fair-value adjustments rose to 25.2%, and HEPS rose 16% to 86.5c. Notable features of the half:

  • The other African countries segment generated 22% of segment profit.

  • Cash reached ZAR 476 M.

  • Head-office costs rose because the share appreciation rights scheme moved to cash settlement, which made reported costs sensitive to the share price.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (ZAR Mn)

5,401.16,020.66,952.66,332.17,146.5

Cost of sales (ZAR Mn)

4,339.04,910.95,769.75,107.35,691.0

Gross profit as reported (ZAR Mn)

1,062.11,109.61,182.91,224.81,455.5

Other gains/(losses) net (ZAR Mn)

72.3-5.9-66.4185.2192.0

Operating profit (ZAR Mn)

147.632.5-35.9230.9368.6

Adjusted operating profit before capital items (ZAR Mn)

144.336.8-34.7232.2360.7

Investment income (ZAR Mn)

4.74.25.58.022.0

Finance costs (ZAR Mn)

11.816.323.619.816.6

Profit before tax (ZAR Mn)

142.320.3-53.0219.9374.9

Income tax expense/(credit) (ZAR Mn)

36.5-3.6-17.459.596.2

Net profit attributable to owners (ZAR Mn)

105.823.8-35.6160.4278.6

Headline earnings (ZAR Mn)

102.328.1-34.8161.3271.7

Basic EPS (ZAR cents)

53.912.0-17.880.0137.8

Diluted EPS (ZAR cents)

53.011.9-17.878.8137.1

HEPS (ZAR cents)

52.214.1-17.480.4134.4

Dividend per share declared for year (ZAR cents)

08.00034.0

Weighted average shares (million)

196.1198.8199.6200.6202.2

Margin (%)

Margin (%)FY2021FY2022FY2023FY2024FY2025

Gross margin as reported

19.718.417.019.320.4

Operating margin

2.70.5-0.53.65.2

Adjusted operating margin

2.70.6-0.53.75.0

Pre-tax margin

2.60.3-0.83.55.2

Net margin

2.00.4-0.52.53.9

Balance Sheet

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (ZAR Mn)

2,784.53,130.82,933.63,215.43,475.9

Property plant and equipment (ZAR Mn)

1,243.11,322.71,353.31,368.21,543.4

Biological assets (ZAR Mn)

403.3433.9338.4460.1460.0

Inventories (ZAR Mn)

383.5463.8415.6361.9367.9

Current trade and other receivables (ZAR Mn)

562.9750.6687.8718.6749.1

Cash and equivalents (ZAR Mn)

73.363.871.4245.8275.9

Intangible assets incl goodwill (ZAR Mn)

7.111.612.39.06.5

Bank overdraft and term loan short-term (ZAR Mn)

074.9020.020.0

Term loan long-term (ZAR Mn)

00079.459.6

Lease liabilities total (ZAR Mn)

109.081.643.243.154.9

Total debt incl leases (ZAR Mn)

109.0156.543.2142.5134.4

Net debt incl leases (ZAR Mn)

35.792.7-28.2-103.3-141.4

Total equity (ZAR Mn)

1,999.82,100.82,015.92,094.72,395.1

Working capital (ZAR Mn)

999.31,006.0861.31,048.91,198.3

Trade and other payables (ZAR Mn)

396.7603.6627.9696.5605.3

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Cash profit from operations (ZAR Mn)

295.3170.6232.2384.9529.9

Working capital change (ZAR Mn)

-259.3-87.152.5-110.1-173.9

Operating cash flow (ZAR Mn)

24.377.8276.4264.3301.8

Capex PPE plus intangibles (ZAR Mn)

108.6125.2142.5153.4261.9

Free cash flow OCF minus capex (ZAR Mn)

-84.3-47.4133.9110.939.9

Dividends paid (ZAR Mn)

19.416.00.10.00.0

Lease principal repaid (ZAR Mn)

20.924.024.919.915.9

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE on year-end equity (%)

5.31.1-1.87.711.6

ROA on year-end assets (%)

3.80.8-1.25.08.0

ROIC indicative after-tax (%)

5.21.1-1.38.511.9

Current ratio (x)

3.352.422.322.422.83

Debt to equity incl leases (%)

5.57.42.16.85.6

Interest cover operating profit / finance costs (x)

12.52.0-1.511.722.3

Asset turnover revenue / year-end assets (x)

1.941.922.371.972.06

Cash conversion cycle indicative (days)

36.935.122.717.522.9

Region revenue (ZAR Mn)

Region revenue (ZAR Mn)FY2021FY2022FY2023FY2024FY2025

South Africa

5,080.95,626.16,509.85,864.26,601.5

Other African countries (Zambia, Uganda, Mozambique)

320.2394.4442.8467.9545.0

Region revenue growth (%)

Region revenue growth (%)FY2022FY2023FY2024FY2025

South Africa

10.715.7-9.912.6

Other African countries

23.212.35.716.5

Region share of group revenue (%)

Region share of group revenue (%)FY2021FY2022FY2023FY2024FY2025

South Africa

94.193.493.692.692.4

Other African countries

5.96.66.47.47.6

Other African countries revenue by product (ZAR Mn)

Other African countries revenue by product (ZAR Mn)FY2021FY2022FY2023FY2024FY2025

Eggs

206.6252.6304.8315.1340.6

Broiler farming (chicks)

33.560.548.074.375.5

Layer farming (pullets)

36.629.134.245.850.6

Animal feeds

43.652.355.832.678.3

Group revenue by product (ZAR Mn)

Group revenue by product (ZAR Mn)FY2021FY2022FY2023FY2024FY2025

Animal feeds

2,484.12,740.53,414.63,171.43,391.7

Broiler farming

1,225.51,436.41,689.51,773.11,787.0

Eggs

1,435.41,602.71,627.11,174.11,603.8

Layer farming

256.2241.0221.4213.5364.1

Share Price History

DatePrice (c)ContextSource

13 Nov 2023

435

Post-HPAI loss trading statement

Business Report

1–7 Mar 2024

+104.4%

Astral stake sold to CBH at 725c

Business Report

2 Dec 2024

850

FY2024 results

Business Report

12 Sep 2025

712—

ShareData

17 Feb 2026

999

SAR modification valuation price

HY2026 note 2

11 Mar 2026

1,190

Pre-AGM

ShareData

30 Apr 2026

1,098

Market cap ZAR 2.24 bn

ShareData

14 Jul 2026

915

Market cap ZAR 1.87 bn

ShareData

13 Oct 2026

741

Latest close

ShareData

Valuation Snapshot

MetricValueBasis

Market capitalisation

ZAR 1 512 M

204.1 M shares

Enterprise value

ZAR 1 152 M

Less net cash of ZAR 359.7 M including leases

TTM revenue

ZAR 6 972 M

FY2025 – HY2025 + HY2026

TTM operating profit

ZAR 405 M

Same method

TTM EPS

153.7c

137.8 – 74.5 + 90.4

TTM HEPS

146.1c

134.4 – 74.8 + 86.5

P/E (on EPS)

4.8x—

P/E (on HEPS)

5.1x—

EV/Sales

0.17x—

EV/operating profit (EBIT)

2.8x—

P/B

0.59x

NAV of 1 249c per share (equity ZAR 2 548 M)

TTM dividend yield

7.6%

34c + 22c = 56c

Dividend per share declared (ZAR cents)

Dividend per share declared (ZAR cents)FY2021FY2022FY2023FY2024FY2025

Interim

08.0000

Final

000034.0

Total

08.00034.0

Capital Instruments

InstrumentAmount (ZAR Mn)TermsMaturity

MYR Bn term loan: current portion

20.0

3-month JIBAR + 2.3% (moving to ZARONIA from Dec 2026); secured by mortgage and notarial bonds of up to ZAR 300 M; semi-annual instalments

Within 12 months

MYR Bn term loan: non-current

49.6

As above

To 30 Sep 2028

IFRS 16 lease liabilities

47.1

Farms, equipment, properties, vehicles; typically 2–5 years

13.2 current; 33.9 non-current

Covenant Details

CovenantLimitActual (31 Mar 2024)

Gross debt to equity

≤30%

2.73%

Equity

≥ZAR 1.8 bn

ZAR 2.02 bn

Current ratio

1.25x

2.65x

EBITDA / senior interest

≥4.5x

18.14x

Analyst Conclusions

Management guidance (HY2026 outlook, 22 May 2026)

Guidance is qualitative only:

  • H2 FY2026 is expected to be significantly more challenging, because Middle East-driven fuel and logistics costs affect both the cost base and consumer spending.

  • Feed raw materials are expected to stay relatively low in the short term.

  • South African egg prices are expected to remain under pressure because of an elevated national flock.

  • HPAI risk remains high, and a vaccination protocol is not yet commercially feasible.

  • No load-shedding is expected, which is positive.

  • Zambia is expected to be stable, Uganda's H1 strength hard to repeat, and Mozambique challenging.

  • New Malmesbury capacity and broiler farm placements will contribute in H2.

Consensus growth expectations

n/d (no published consensus).

Bull case

  1. Structural de-risking is working. Feed, broiler and Africa together generated ZAR 208.7 M of HY2026 adjusted operating profit, against ZAR 41.5 M from eggs. A lower-volatility earnings base deserves a higher multiple than about 5x earnings and 0.6x book.

  2. Capacity is arriving into demand. The Malmesbury mill was at full capacity before expansion; day-old broiler chick volumes rose 9.1% after the northern breeder conversions; and the Western Cape broiler conversion adds about 6% capacity. Volume growth could offset deflation in feed and egg prices.

  3. Cash and a corporate catalyst. Net cash of about ZAR 360 M (about 24% of market cap) and a 7.6% trailing yield. The two ROFR blocs make an eventual control transaction plausible, which could crystallise value toward NAV of 1 249c, about 69% above 741c.

Bear case

  1. Eggs are entering a down-cycle. Management's own 18–24-month egg recovery forecast, the record national flock and the -8.8% HY2026 price move imply further egg-margin erosion. Any rise in feed costs would amplify losses, as in FY2022 and FY2023.

  2. HPAI remains an unhedged tail risk. A single severe outbreak cost ZAR 155 M in FY2023, more than half of FY2025 net profit. A commercially workable vaccination protocol is still absent.

  3. Governance is deteriorating, not stabilising. NED pay was rejected again in October 2026 (79.90% against the chair's back-pay). The blockholders include direct competitors. Free float is about 3% and institutional holding zero. The shares can stay structurally discounted with no market mechanism to close the gap.

Key catalysts and monitorables (next 12 months)

Expected timingCatalyst
~Nov 2026FY2026 trading statement, then audited results. Watch H2 egg margins, feed volumes from Malmesbury, and the final dividend decision
OngoingBoard response to the failed NED remuneration resolutions (5 Oct 2026). Possible chair change, requisitioned meetings or a revised proposal
OngoingAny exercise of the ROFRs or acquisition by Capitalworks, Aristotle, CBH or Braemar. A move above 35% would trigger a mandatory offer under SA takeover rules
OngoingSeasonal HPAI incidence (southern-hemisphere winter, May–Sep) and progress on a vaccination protocol
OngoingCompetition Commission Poultry Market Inquiry findings (about early-to-mid 2027)
~Mar 2027FY2026 AGM. NED remuneration and director elections become a referendum on the chair
OngoingMozambique transaction; Zambian Copperbelt build progress; Golden appeal outcome
OngoingAstral broiler supply agreement visibility ahead of its roughly 2029 expiry

Analyst verdict

Operationally, Quantum Foods enters FY2027 in better shape than at any point since its 2014 unbundling. It has recovered from back-to-back avian influenza disasters to deliver FY2025 HEPS of 134.4c and a further 16% rise in HY2026. The balance sheet is net cash. It has a newly commissioned feed mill, rebalanced breeder capacity and a fast-growing African business that now contributes more than a fifth of segment profit.

Management has executed credibly on a clear strategy: shift capital toward the less cyclical feed and broiler businesses, rightsize the volatile egg business, and diversify geographically. On the numbers alone, a stock trading at about 5x trailing earnings, 0.6x book and a 7.6% yield looks mispriced.

The discount, however, is not an accident. Quantum is in effect a listed private company. Four blockholders control about 97% of the shares; two of them own competing poultry businesses; and they are arranged in opposing ROFR blocs that could each approach or exceed control. The board has survived one removal vote by a 1.6-percentage-point margin. A court has ordered a director reinstated. And shareholders have now twice refused to pay the non-executives, most recently voting almost four-to-one against the chairman's remuneration.

That conflict is unlikely to resolve organically. It is more likely to end in a control transaction, a board reconstitution, or prolonged attrition that distracts management during an egg down-cycle.

Our synthesis is that Quantum is a fundamentally improving but un-investable-at-scale special situation. Value realisation depends less on operations than on how the shareholder contest is resolved. For strategic or event-driven investors, the asymmetry is attractive: downside is cushioned by net cash and tangible assets, and upside comes from a potential offer toward NAV. For conventional institutional mandates, illiquidity, concentration, HPAI tail risk and a governance standoff that worsened in October 2026 remain disqualifying until a resolution is visible.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

DirectorRoleIndependenceAppointed / tenureBackground (as disclosed in sources reviewed)

Wouter André (André) Hanekom

Chairman, non-executive

Not classified independent

Board since 2014; chair since 2015

Former CEO of Pioneer Foods. Survived removal votes in Sep 2024 (49.21% for removal). Re-elected Mar 2026

Geoffrey George Fortuin

Lead independent director; Audit and Risk Committee (ARC) chair

Independent

Board since at least 2022 (exact date n/d)

Survived removal vote in Sep 2024

Larry Wilson Riddle

Independent NED; ARC member

Independent

Board since at least 2022 (exact date n/d)

Braemar sought his removal in 2024 (meeting never convened)

Gary Vaughan-Smith

Non-executive director

Not classified independent

Board since at least 2022 (exact date n/d)

Widely associated with SilverStreet Capital, adviser to Silverlands II / Aristotle Africa (the largest shareholder). Confirm against the 2025 IR board biography

Pieter Francois Theron (Piet) Burger

Independent NED; ARC and SETC member

Independent

29 Jul 2024

BEng (Chemical) and MBA (Stellenbosch); former executive at Tiger Brands and Pioneer Foods; more than 30 years in manufacturing

RW Dobbie

Independent NED

Independent

Elected 26 Mar 2026

Biography n/d in sources reviewed

JG Hudson

Independent NED

Independent

Elected 26 Mar 2026

Biography n/d in sources reviewed

SBC Johnson

Independent NED

Independent

Elected 26 Mar 2026

Biography n/d in sources reviewed

S Reid

Independent NED

Independent

Elected 26 Mar 2026

Biography n/d in sources reviewed

Adel Deidré van der Merwe

Chief Executive Officer

Executive

CEO since 1 Apr 2024

Prior Quantum roles n/d in sources reviewed

André Hugo Muller

Chief Financial Officer

Executive

CFO since at least FY2020 (exact date n/d)

CA(SA)

Board & Management Changes

DateChange

1 Apr 2024

HA (Hennie) Lourens retires as CEO (leaves board 31 May 2024); AD van der Merwe appointed CEO

31 May 2024

TJA Golden leaves the board (disputed as a "summary removal"; WC High Court ordered reinstatement in Nov 2024; leave to appeal sought)

29 Jul 2024

PFT Burger appointed independent NED

11 Sep 2024

Shareholder resolutions to remove Hanekom, Fortuin and Burger fail

26 Mar 2026

RW Dobbie, JG Hudson, SBC Johnson and S Reid elected independent NEDs

7 and 9 Apr 2026

"Director's integrity information" announcements published (content n/d in sources reviewed)

Major Shareholders

HolderUltimate partyLatest disclosed / estimated stakeBasis and date

Aristotle Africa S.à r.l.

Silverlands II SCSp (advised by SilverStreet Capital LLP, London)

~34.2–34.5%

34.2% per company statement Mar 2024 (Just Food). Profile's Handbook lists a 34.46% holder (Jun/Oct 2025); attribution inferred

Braemar Trading Ltd

Associated with the Rudland family (Zimbabwe)

~30.5–31%

30.8% in Mar 2024. Implied about 30.5% from the CBH and Braemar combined 47.54% (Jul 2025)

Country Bird Holdings (Pty) Ltd (CBH)

Private SA poultry integrator

~17.0–18%

15.8% in Mar 2024, about 18% by Jul 2024 (BusinessDay). Profile's Handbook lists a 17.04% holder

Capitalworks Private Equity SP GP II (Special Purpose Acquisition Partnership IV) with Crown Chickens (Pty) Ltd (Sovereign Food Investments subsidiary)

Capitalworks Investment Partners

15.53% of net shares

SENS 12 Jun 2025

Directors and other public

—

~2–3% (implied residual)

Analyst-computed residual

Competitive Landscape

Key Competitors

CompetitorSegments overlappingStatusLatest revenuePositioning vs Quantum

Astral Foods (JSE: ARL)

Feed (Meadow Feeds), broiler breeding and day-old chicks, broilers

Listed

ZAR 22.6 bn FY2025 (Sep YE); PBIT ZAR 1.25 bn

About 3x Quantum's scale; also Quantum's largest broiler customer. Led the HPAI vaccination pilot

Rainbow Chicken (JSE: RBO; unbundled from RCL Jul 2024)

Broilers, animal feed (Epol, Driehoek)

Listed

ZAR 17.1 bn FY2026 (Jun YE); EBITDA ZAR 2.13 bn

About 390 000 t of chicken and about 1 M t of feed a year (BusinessDay, Aug 2026)

Country Bird Holdings (CBH)

Feed, broiler breeding, broilers

Private; about 17–18% Quantum shareholder

—

Larger broiler producer (about 75 M birds vs Quantum's 45 M+ per WATTAgNet ranking)

Sovereign Foods / Crown Chickens (Capitalworks)

Broilers, feed

Private; about 15.5% Quantum shareholder (via Capitalworks)

—

Eastern Cape-based integrator

AFGRI Animal Feeds

Feed

Private

—

National feed competitor

Daybreak Farms

Broilers, feed

Private

—

Northern-region broiler competitor

Other SA egg producers (for example Eggbert Eggs and regional producers)

Eggs, layer livestock

Mostly private

—

A fragmented egg market. Quantum is described as one of the largest egg suppliers

Other SA layer-genetics distributors

Layer livestock

Private

—

Compete with Bergvlei / Lohmann

Zambeef Products (LuSE/AIM)

Zambia: feed, poultry, eggs

Listed

n/d in sources reviewed

Largest integrated Zambian protein group

Other Zambian and Ugandan hatcheries and feed millers

Other African countries

Private

—

Competing day-old chick and feed suppliers

Peer Comparison FY2025

MetricQuantum Foods (FY Sep 2025)Astral Foods (FY Sep 2025)Rainbow Chicken (FY Jun 2026)RCL Foods (FY Jun 2025)

Revenue (ZAR Bn)

7.1522.617.126.5

Revenue growth (%)

12.910.47.71.8

Operating / PBIT margin (%)

5.25.5

n/d (EBITDA margin about 12.5%)

n/d (EBITDA margin about 9.7%)

Headline EPS (cents)

134.42,193150.87—

Dividend per share (cents)

341,100

135 (incl. 75c special)

60

Company Snapshot

$397M

Revenue

2

Employees

2013

Founded

Wellington, South Africa

Headquarters

SWOT Analysis

Strengths

  • Net-cash balance sheet: ZAR 359.7 M net cash including leases at 31 Mar 2026. Debt is limited to a ZAR 69.6 M RMB term loan plus ZAR 47.1 M of leases (HY2026).
  • Recovered profitability: FY2025 HEPS of 134.4c, versus a 17.4c loss in FY2023. ROE improved from -1.8% to 11.6% (analyst-computed).
  • Resilient feed engine: adjusted operating profit of ZAR 93–104 M in each of FY2021–FY2025, including the FY2023 crisis year.
  • Genetics position: the Lohmann grandparent import licence, with exclusive South African parent-stock distribution (2025 IR).
  • Contracted broiler offtake: about 600 000 birds a week to Astral, about 35% of County Fair capacity (Astral, Mar 2024), plus the 40% Klipvlei associate.
  • Fast-growing African platform: Other African countries revenue CAGR of 14.2% (FY2021–FY2025); HY2026 profit of ZAR 51.5 M vs ZAR 14.1 M.

Weaknesses

  • Thin group margins: adjusted operating margin of 5.0% in FY2025 was the best of five years; FY2022 and FY2023 were 0.6% and -0.5%.
  • Earnings concentration in volatile eggs: the eggs segment swung from ZAR -42 M (FY2023) to ZAR +140 M (FY2024) to ZAR +111 M (FY2025).
  • Low free cash flow conversion: cumulative FY2021–FY2025 free cash flow was about ZAR 153 M against cumulative net profit of about ZAR 533 M (analyst-computed).
  • Governance dysfunction: the 2025 AGM rejected NED fees; the Oct 2026 votes ran up to 79.90% against the chair's remuneration; the Golden court ruling (Nov 2024).
  • Negligible free float and liquidity: the top four holders own about 97%; institutional holding is about 0%; trades are frequently a handful of deals or fewer a day (ShareData).
  • No processing capability: cannot capture broiler-meat margin upswings that peers such as Rainbow (FY2026 HEPS +130%) are currently enjoying.

Opportunities

  • Malmesbury capacity (ZAR 194 M) came online in Feb 2026 into a mill that had been running at full capacity in FY2025.
  • Broiler expansion: about +6% live-bird capacity from the Western Cape conversion; the northern breeder conversions lifted day-old chick volumes 9.1% in HY2026.
  • Zambian Copperbelt greenfield egg and feed project; Zambia positioned as a regional hub (2025 IR).
  • HPAI vaccination: ZA-certified farms could unlock layer growth if commercially feasible protocols are agreed.
  • Informal and depot channels: formal retail fell to 46.2% of egg volume, and the Quantum Nest Eggs brand is being built.
  • A control transaction: the ROFR structures imply a potential change of control. A future offer to minorities is possible but explicitly not intended at present (SENS Jun/Jul 2025).

Threats

  • HPAI recurrence: ZAR 155.3 M lost in FY2023, ZAR 37 M in FY2024, and an Oct 2025 Western Cape outbreak affecting about 153 000 hens.
  • Egg down-cycle: management forecasts 18–24 months of pressure from the record national flock (2025 IR).
  • Competitor feed pricing: external feed volumes -3.8% in HY2026 (HY2026).
  • Geopolitical cost shock: Middle East conflict lifting fuel and fertiliser costs, per management's H2 FY2026 warning.
  • Regulatory scrutiny: the Competition Commission Poultry Market Inquiry; two EIA administrative penalties (under appeal).
  • Blockholder conflict of interest: CBH and Capitalworks/Sovereign are competitors with board-influencing stakes, raising the risk of strategic paralysis or a control contest.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
23 May 2025HY2025 results: revenue +20% to ZAR 3.6 bn; adjusted operating profit +234% to ZAR 205 M; HEPS 74.8c; no interim dividendConfirms post-HPAI recovery
Jun 2025Mobile egg-placement machine arrives from Belgium for the on-farm hatching pilotInnovation
12 Jun 2025Capitalworks and Crown Chickens reach 15.53%; reciprocal ROFR with Aristotle (together >50%)Potential control shift
15–18 Jul 2025CBH and Braemar sign a reciprocal ROFR (47.54% combined)Counter-bloc formed
Jul 2025Objection lodged after government declines HPAI compensation for 2023–24 cullsRegulatory
Sep 2025Uganda hatchery adds a 7th setter/hatcher unitCapacity
30 Sep 2025Competition Commission publishes Poultry Market Inquiry terms of reference (eggs and broilers; inquiry from Oct 2025, about 18 months)Regulatory overhang
Early Oct 2025HPAI at a Western Cape layer farm (about 153 000 hens); ZAR 8.2 M impairment booked as an adjusting post-balance-sheet eventDisease risk materialised
17 Nov 2025NEDs (except the chair) appointed to the QF subsidiary board to enable fee paymentsGovernance workaround
Nov 2025Last HPAI outbreak reported in South Africa, at a KwaZulu-Natal broiler farm, to the company's knowledgeIndustry
25 Nov 2025Board approves FY2025 AFS and Integrated ReportReporting
28 Nov 2025FY2025 results: revenue ZAR 7.15 bn (+12.9%); HEPS 134.4c (+67%); final dividend 34cBest result in years; dividend reinstated
Dec 20252025 Integrated Report and climate-related risk disclosure publishedESG reporting
26 Jan 2026Final dividend paid (about ZAR 69 M)Capital return
30 Jan 2026AGM notice issued (a duplicate notice was cancelled and reissued the same day)Administrative
Feb 2026Malmesbury feed-mill expansion completedCapacity for H2 FY2026
17–23 Feb 2026Share appreciation rights scheme moved to cash settlement; scheme share cap exhaustedP&L exposed to share price
26 Mar 2026AGM: all resolutions passed; four new independent NEDs elected; EY reappointedBoard refresh
7 and 9 Apr 2026Two "director's integrity information" announcementsGovernance disclosure
6 May 2026Trading statement: HEPS expected +12% to +20%Earnings visibility
May 2026First placements expected at the converted Western Cape broiler farmVolume growth
22 May 2026HY2026 results: HEPS +16% to 86.5c; interim dividend 22c; net cash about ZAR 360 MMargin-led growth
HY2026Ugandan breeder farm sold; Zambian Copperbelt farm acquiredPortfolio reshaping
24 Jun 2026Valeo Capital appointed JSE sponsor, replacing One CapitalAdviser change
29 Jun 2026Interim dividend paidCapital return
Apr–Oct 2026Share price falls from about 1 190c (early Apr) to 741c (13 Oct), about -38%Market de-rating amid governance conflict and the H2 outlook
27 Aug 2026NED remuneration restructure circular (s60 written resolutions)Governance
5 Oct 2026All three NED remuneration resolutions defeated (up to 79.90% against)Escalation of shareholder conflict
Dec 2026 (upcoming)JIBAR to ZARONIA transition for the RMB term loanTechnical

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Income Statement: Revenue & Gross Profit: Revenue rose from ZAR 5,401.1 Mn in FY2021 to ZAR 7,146.5 Mn in FY2025.
Quantum Foods Holdings Ltd — Income Statement: Revenue & Gross Profit
Series (ZAR Mn)FY2021FY2022FY2023FY2024FY2025
Revenue5,401.16,020.66,952.66,332.17,146.5
Cost of sales4,3394,910.95,769.75,107.35,691
Gross profit as reported1,062.11,109.61,182.91,224.81,455.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Quantum Foods, Unaudited interim financial statements HY2026 (quantumfoods.co.za)
  2. Quantum Foods, Unaudited interim financial statements HY2025 (quantumfoods.co.za)
  3. Quantum Foods, Unaudited interim financial statements HY2024 (quantumfoods.co.za)
  4. Quantum Foods, Annual financial statements FY2025 (quantumfoods.co.za)
  5. Quantum Foods, Integrated Report 2025 (quantumfoods.co.za)
  6. Quantum Foods, Summary audited results FY2022 (with FY2021 comparatives) (quantumfoods.co.za)
  7. Quantum Foods, Reports and results index (quantumfoods.co.za)
  8. JSE SENS, FY2023 results (1 Dec 2023) (senspdf.jse.co.za)
  9. JSE SENS, FY2023 updated trading statement (10 Nov 2023) (senspdf.jse.co.za)
  10. JSE SENS, FY2022 results (25 Nov 2022) (senspdf.jse.co.za)
  11. JSE SENS, Results of general meeting (12 Sep 2024) (senspdf.jse.co.za)
  12. JSE SENS, Capitalworks 11.44% (6 Sep 2024) (senspdf.jse.co.za)
  13. JSE SENS, CBH demand (25 Jul 2024) (senspdf.jse.co.za)
  14. JSE SENS, Burger appointment (30 Jul 2024) (senspdf.jse.co.za)
  15. JSE SENS, Golden resignation notice (31 May 2024) (senspdf.jse.co.za)
  16. JSE SENS, CBH / Braemar ROFR (18 Jul 2025) (senspdf.jse.co.za)
  17. JSE SENS, Astral disposal notice (7 Mar 2024) (senspdf.jse.co.za)
  18. JSE SENS, Aristotle acquisition (24 Jul 2020) (senspdf.jse.co.za)
  19. ShareData SENS, Capitalworks / Aristotle ROFR (12 Jun 2025) (sharedata.co.za)
  20. ShareData SENS, NED remuneration circular (27 Aug 2026) (sharedata.co.za)
  21. ShareData SENS, Results of special resolutions (5 Oct 2026) (sharedata.co.za)
  22. ShareData SENS, Trading statement (6 May 2026) (sharedata.co.za)
  23. ShareData SENS, AGM results (27 Mar 2026) (sharedata.co.za)
  24. ShareData SENS, AGM results (24 Mar 2025) (sharedata.co.za)
  25. ShareData, QFH latest news and price (sharedata.co.za)
  26. Astral Foods, Disposal of Quantum interest (6 Mar 2024) (astralfoods.com)
  27. Astral Foods, FY2025 results (17 Nov 2025) (senspdf.jse.co.za)
  28. BusinessDay, Rainbow FY2026 (31 Aug 2026) (businessday.co.za)
  29. Engineering News, Rainbow FY2026 results (28 Aug 2026) (engineeringnews.co.za)
  30. BusinessDay, Capitalworks stake (8 Sep 2024) (businessday.co.za)
  31. BusinessDay, Boardroom war in court (25 Jul 2024) (businessday.co.za)
  32. Food Business MEA, FY2024 results and Golden ruling (foodbusinessmea.com)
  33. Just Food, CBH stake from Astral (Mar 2024) (just-food.com)
  34. WATTAgNet, Strong interest in Quantum Foods (2020) (wattagnet.com)
  35. Daily Investor, NED remuneration vote (Oct 2026) (dailyinvestor.com)
  36. Engineering News, Pioneer to unbundle Quantum (5 Sep 2014) (engineeringnews.co.za)
  37. Business Report, FY2025 results (28 Nov 2025) (businessreport.co.za)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.